chr9-21206845-G-A
Variant names:
Variant summary
Our verdict is Likely benign. The variant received -3 ACMG points: 1P and 4B. PP5BS2
The NM_002171.2(IFNA10):c.253C>T(p.Gln85*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000508 in 1,613,530 control chromosomes in the GnomAD database, including 14 homozygotes. Variant has been reported in ClinVar as Likely risk allele (no stars).
Frequency
Genomes: 𝑓 0.0030 ( 6 hom., cov: 31)
Exomes 𝑓: 0.00024 ( 8 hom. )
Consequence
IFNA10
NM_002171.2 stop_gained
NM_002171.2 stop_gained
Scores
1
3
3
Clinical Significance
Conservation
PhyloP100: 0.566
Genes affected
IFNA10 (HGNC:5418): (interferon alpha 10) This gene encodes a protein that belongs to the type I interferon family of proteins, and is located in a cluster of alpha interferon genes on chromosome 9. Interferons are small regulatory molecules that function in cell signaling in response to viruses and other pathogens or tumor cells. This gene is intronless and the encoded protein is secreted. [provided by RefSeq, Aug 2013]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Likely_benign. The variant received -3 ACMG points.
PP5
Variant 9-21206845-G-A is Pathogenic according to our data. Variant chr9-21206845-G-A is described in ClinVar as [Likely_risk_allele]. Clinvar id is 2428777.Status of the report is no_assertion_criteria_provided, 0 stars. We mark this variant Likely_pathogenic, oryginal submission is: [Likely_risk_allele].
BS2
High Homozygotes in GnomAd4 at 6 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
IFNA10 | NM_002171.2 | c.253C>T | p.Gln85* | stop_gained | Exon 1 of 1 | ENST00000357374.2 | NP_002162.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00306 AC: 465AN: 151754Hom.: 6 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
465
AN:
151754
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.000729 AC: 182AN: 249636 AF XY: 0.000481 show subpopulations
GnomAD2 exomes
AF:
AC:
182
AN:
249636
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000244 AC: 357AN: 1461658Hom.: 8 Cov.: 33 AF XY: 0.000172 AC XY: 125AN XY: 727136 show subpopulations
GnomAD4 exome
AF:
AC:
357
AN:
1461658
Hom.:
Cov.:
33
AF XY:
AC XY:
125
AN XY:
727136
Gnomad4 AFR exome
AF:
AC:
297
AN:
33466
Gnomad4 AMR exome
AF:
AC:
23
AN:
44710
Gnomad4 ASJ exome
AF:
AC:
0
AN:
26130
Gnomad4 EAS exome
AF:
AC:
0
AN:
39698
Gnomad4 SAS exome
AF:
AC:
1
AN:
86250
Gnomad4 FIN exome
AF:
AC:
0
AN:
53418
Gnomad4 NFE exome
AF:
AC:
2
AN:
1111852
Gnomad4 Remaining exome
AF:
AC:
29
AN:
60372
Heterozygous variant carriers
0
21
42
64
85
106
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00305 AC: 463AN: 151872Hom.: 6 Cov.: 31 AF XY: 0.00284 AC XY: 211AN XY: 74224 show subpopulations
GnomAD4 genome
AF:
AC:
463
AN:
151872
Hom.:
Cov.:
31
AF XY:
AC XY:
211
AN XY:
74224
Gnomad4 AFR
AF:
AC:
0.0106754
AN:
0.0106754
Gnomad4 AMR
AF:
AC:
0.000983994
AN:
0.000983994
Gnomad4 ASJ
AF:
AC:
0
AN:
0
Gnomad4 EAS
AF:
AC:
0
AN:
0
Gnomad4 SAS
AF:
AC:
0
AN:
0
Gnomad4 FIN
AF:
AC:
0
AN:
0
Gnomad4 NFE
AF:
AC:
0.0000294196
AN:
0.0000294196
Gnomad4 OTH
AF:
AC:
0.00236518
AN:
0.00236518
Heterozygous variant carriers
0
20
40
60
80
100
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
37
ESP6500EA
AF:
AC:
0
ExAC
AF:
AC:
109
ClinVar
Significance: Likely risk allele
Submissions summary: Pathogenic:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
Susceptibility to severe COVID-19 Pathogenic:1
Jul 01, 2022
Al Jalila Children’s Genomics Center, Al Jalila Childrens Speciality Hospital
Significance:Likely risk allele
Review Status:no assertion criteria provided
Collection Method:research
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Uncertain
D
BayesDel_noAF
Pathogenic
DANN
Uncertain
Eigen
Uncertain
Eigen_PC
Benign
FATHMM_MKL
Benign
N
Vest4
GERP RS
Mutation Taster
=182/18
polymorphism
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at